Evaluation of serum-free differentiation conditions for C2C12 myoblast cells assessed as to active tension generation capability

Biotechnology and Bioengineering

Volumn 107, Issue 5, 2010, Pages 894-901

  Fujita, Hideaki ^a   Endo, Akiko ^a   Shimizu, Kazunori ^a   Nagamori, Eiji ^a  

^a Rd Management Section   (Japan)

Author keywords

AIM V; C2C12; F 12; Muscle; Serum free; Ultroser G

Indexed keywords

AIM-V; C2C12; F-12; SERUM-FREE; ULTROSER-G;

ASYMPTOTIC ANALYSIS; CELLS; GLUCOSE; HYDRAULIC STRUCTURES; MUSCLE;

BODY FLUIDS;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; GLUCOSE INTAKE; GLUCOSE METABOLISM; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; SARCOMERE;

ANIMALS; CELL DIFFERENTIATION; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE TONUS; MYOBLASTS;

EQUIDAE;

EID: 77958593633     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22865     Document Type: Article

References (26)

1. Bach AD, Beier JP, Stern-Staeter J, Horch RE. 2004. Skeletal muscle tissue engineering. J Cell Mol Med 8(4): 413-422.
2. Benders AA, van Kuppevelt TH, Oosterhof A, Veerkamp JH. 1991. The biochemical and structural maturation of human skeletal muscle cells in culture: The effect of the serum substitute Ultroser G. Exp Cell Res 195(2): 284-294.
3. Chase LG, Firpo MT. 2007. Development of serum-free culture systems for human embryonic stem cells. Curr Opin Chem Biol 11(4): 367-372.
4. Conejo R, Valverde AM, Benito M, Lorenzo M. 2001. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J Cell Physiol 186(1): 82-94.
5. Cossu G, Sampaolesi M. 2007. New therapies for Duchenne muscular dystrophy: Challenges, prospects and clinical trials. Trends Mol Med 13(12): 520-526.
6. Das M, Rumsey JW, Bhargava N, Gregory C, Riedel L, Kang JF, Hickman JJ. 2009. Developing a novel serum-free cell culture model of skeletal muscle differentiation by systematically studying the role of different growth factors in myotube formation. In Vitro Cell Dev Biol Anim 45(7): 378-387.
7. Dennis RG, Kosnik PE II, Gilbert ME, Faulkner JA. 2001. Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines. Am J Physiol Cell Physiol 280(2): C288-C295.
8. Even MS, Sandusky CB, Barnard ND. 2006. Serum-free hybridoma culture: Ethical, scientific and safety considerations. Trends Biotechnol 24(3): 105-108.
9. Florini JR, Ewton DZ, Coolican SA. 1996. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17(5): 481-517.
10. Froud SJ. 1999. The development, benefits and disadvantages of serum-free media. Dev Biol Stand 99:157-166.
11. Fujita H, Shimizu K, Nagamori E. 2009. Novel method for fabrication of skeletal muscle construct from the C2C12 myoblast cell line using serum-free medium AIM-V. Biotechnol Bioeng 103(5): 1034-1041.
12. Fujita H, Shimizu K, Nagamori E. 2010. Novel method for measuring active tension generation by C2C12 myotube using UV-crosslinked collagen film. Biotechnol Bioeng 106(3): 482-489.
13. Gawlitta D, Boonen KJ, Oomens CW, Baaijens FP, Bouten CV. 2008. The influence of serum-free culture conditions on skeletal muscle differentiation in a tissue-engineered model. Tissue Eng Part A 14(1): 161-171.
14. Goto S, Miyazaki K, Funabiki T, Yasumitsu H. 1999. Serum-free culture conditions for analysis of secretory proteinases during myogenic differentiation of mouse C2C12 myoblasts. Anal Biochem 272(2): 135-142.
15. Ham RG. 1965. Clonal growth of mammalian cells in a chemically defined, synthetic medium. Proc Natl Acad Sci USA 53:288-293.
16. Helinski EH, Bielat KL, Ovak GM, Pauly JL. 1988. Long-term cultivation of functional human macrophages in Teflon dishes with serum-free media. J Leukoc Biol 44(2): 111-121.
17. Lawson MA, Purslow PP. 2000. Differentiation of myoblasts in serum-free media: Effects of modified media are cell line-specific. Cells Tissues Organs 167(2-3): 130-137.
18. Lebkowski JS, Schain LR, Okarma TB. 1995. Serum-free culture of hematopoietic stem cells: A review. Stem Cells 13(6): 607-612.
19. Lubiniecki AS. 1999. Elimination of serum from cell culture medium. Dev Biol Stand 99:153-156.
20. Morrow KJ, Jr. 2007. Advances in antibody manufacturing using mammalian cells. Biotechnol Annu Rev 13:95-113.
21. Nicole S, Diaz CC, Frugier T, Melki J. 2002. Spinal muscular atrophy: Recent advances and future prospects. Muscle Nerve 26(1): 4-13.
22. Okano T, Satoh S, Oka T, Matsuda T. 1997. Tissue engineering of skeletal muscle. Highly dense, highly oriented hybrid muscular tissues biomimicking native tissues. ASAIO J 43(5): M749-M753.
23. Portier GL, Benders AG, Oosterhof A, Veerkamp JH, van Kuppevelt TH. 1999. Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cell Dev Biol Anim 35(4): 219-227.
24. Stern-Straeter J, Riedel F, Bran G, Hormann K, Goessler UR. 2007. Advances in skeletal muscle tissue engineering. In Vivo 21(3): 435-444.
25. Sultan KR, Henkel B, Terlou M, Haagsman HP. 2006. Quantification of hormone-induced atrophy of large myotubes from C2C12 and L6 cells: Atrophy-inducible and atrophy-resistant C2C12 myotubes. Am J Physiol Cell Physiol 290(2): C650-C659.
26. Terada S, Nishimura T, Sasaki M, Yamada H, Miki M. 2002. Sericin, a protein derived from silkworms, accelerates the proliferation of several mammalian cell lines including a hybridoma. Cytotechnology 40(1-3): 3-12.